The Commission on Cancer of the American College of Surgeons has recognized the cancer programs at Beaumont hospitals in Grosse Pointe, Royal Oak, and Troy as Outstanding Achievement Award recipients.
“The Outstanding Achievement Award acknowledges cancer programs that achieve excellence in providing quality care to cancer patients,” says Thomas Lanni, vice president of Oncology, Medicine, and Imaging at Beaumont Hospital in Royal Oak.
After an April survey, all three hospitals, as well as the health system’s cancer programs at Dearborn and Farmington Hills, also earned reaccreditation as Integrated Network Cancer Programs from the Commission on Cancer.
To earn voluntary accreditation, a cancer program must meet or exceed 34 quality care standards, be evaluated every three years through a survey process, and maintain levels of excellence in the delivery of patient-centered care.
The accreditation program provides the framework for Beaumont Health’s cancer program to ensure that patients receive quality care close to home, a multidisciplinary team approach, options for genetic assessment and counseling, care monitoring, treatment planning based on national treatment guidelines, new treatment options, patient tracking through the cancer data system, and more.
There are 1,500 Commission on Cancer accredited cancer programs nationwide, representing 30 percent of all hospitals. Commission on Cancer accredited facilities diagnose and treat more than 70 percent of all newly diagnosed cancer patients each year.
Beaumont’s cancer program combines the expertise of surgical, medical, and radiation oncologists to offer cancer prevention counseling, diagnosis, and treatment in hospital and community-based settings. The Beaumont Cancer Institute is one of only 34 community sites in the U.S. to be awarded a five-year National Cancer Institute Community Oncology Research Program grant.
